-
公开(公告)号:UA125032C2
公开(公告)日:2021-12-29
申请号:UAA201904246
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN W , ARONOW SEAN , BLAKE JAMES F , BRANDHUBER BARBARA J , COLLIER JAMES , COOK ADAM , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , MCNULTY OREN T , METCALF ANDREW T , MORENO DAVID A , RAMANN GINELLE A , TANG TONY P , REN LI , WALLS SHANE M
Abstract: ВданомудокументізапропонованісполукиФормулиІ: абоїхфармацевтичноприйнятнасіль, абосольват, деА, В, X1, X2, X3, X4, кільце D, Е, Ra, Rb, n і m маютьзначення, наведенів описі, якіявляютьсобоюінгібітори RET-кіназиі корисніприлікуванніі профілактицізахворювань, якіможутьлікуватисяінгібітором RET-кінази, включаючизахворюваннятарозлади, пов'язаніз RET.
-
公开(公告)号:EA037208B1
公开(公告)日:2021-02-19
申请号:EA201990939
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN W , ARONOW SEAN , BLAKE JAMES F , BRANDHUBER BARBARA J , COLLIER JAMES , COOK ADAM , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , MCNULTY OREN T , METCALF ANDREW T , MORENO DAVID A , RAMANN GINELLE A , TANG TONY P , REN LI , WALLS SHANE M
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: Вданномдокументепредложенысоединенияформулы Iилиихфармацевтическиприемлемаясоль, где A, B, X1, X2, X3, X4, кольцо D, E, Ra, Rb, n и m имеютзначения, приведенныев описании, которыеявляютсяингибиторами RET киназыи полезныприлечениии профилактикезаболеваний, которыемогутлечитьсяингибитором RET киназы, включаязаболеванияи расстройства, связанныес RET.
-
公开(公告)号:TN2019000107A1
公开(公告)日:2020-10-05
申请号:TN2019000107
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , JIANG YUTONG , ARONOW SEAN , COOK ADAM , MORENO DAVID A , RAMANN GINELLE A , ANDREWS STEVEN W , TANG TONY P , BRANDHUBER BARBARA J , COLLIER JAMES , MCNULTY OREN T , REN LI , BLAKE JAMES F , METCALF ANDREW T , WALLS SHANE M , HAAS JULIA
IPC: A61P35/00 , A61K31/437 , C07D471/04
Abstract: Provided herein are compounds of the Formula (I), or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X 1 , X 2 , X 3 , X 4 , Ring D, E, R a , R b , n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
-
公开(公告)号:AU2017342027A1
公开(公告)日:2019-05-23
申请号:AU2017342027
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN W , ARONOW SEAN , BLAKE JAMES F , BRANDHUBER BARBARA J , COLLIER JAMES , COOK ADAM , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , MCNULTY OREN T , METCALF ANDREW T , MORENO DAVID A , RAMANN GINELLE A , TANG TONY P , REN LI , WALLS SHANE M
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: Provided herein are compounds of the Formula I: (I) or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X
-
公开(公告)号:CA3039912A1
公开(公告)日:2018-04-19
申请号:CA3039912
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN W , ARONOW SEAN , BLAKE JAMES F , BRANDHUBER BARBARA J , COLLIER JAMES , COOK ADAM , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , MCNULTY OREN T , METCALF ANDREW T , MORENO DAVID A , RAMANN GINELLE A , TANG TONY P , REN LI , WALLS SHANE M
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: Provided herein are compounds of the Formula I: (I) or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X1, X2, X3, X4, Ring D, E, Ra, Rb, n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
-
公开(公告)号:MA46463B1
公开(公告)日:2022-10-31
申请号:MA46463
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: TANG TONY P , JIANG YUTONG , ANDREWS STEVEN W , REN LI , HAAS JULIA , ARONOW SEAN , BRANDHUBER BARBARA J , COOK ADAM , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , METCALF ANDREW T , MORENO DAVID A , BLAKE JAMES F , COLLIER JAMES , MCKNULTY OREN T , RAMANN GINELLE A , WALLS SHANE M
IPC: A61K31/437 , A61P35/00 , C07D471/04
Abstract: L'invention concerne des composés de formule i : (i) ou un sel ou un solvate pharmaceutiquement acceptable de ceux-ci, dans laquelle a, b, x 1 , x 2 , x 3 , x 4 , le cycle d, e, r a , r b , n et m ont les significations données dans la description, qui sont des inhibiteurs de la kinase ret et sont utiles dans le traitement et la prévention de maladies qui peuvent être traitées avec un inhibiteur de kinase ret, y compris des maladies et des troubles associés à ret.
-
公开(公告)号:PL3523302T3
公开(公告)日:2022-10-24
申请号:PL17787844
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN W , ARONOW SEAN , BLAKE JAMES F , BRANDHUBER BARBARA J , COLLIER JAMES , COOK ADAM , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , MCKNULTY OREN T , METCALF ANDREW T , MORENO DAVID A , RAMANN GINELLE A , TANG TONY P , REN LI , WALLS SHANE M
IPC: C07D471/04 , A61K31/437 , A61P35/00
-
公开(公告)号:ES2926136T3
公开(公告)日:2022-10-24
申请号:ES17787844
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN W , ARONOW SEAN , BLAKE JAMES F , BRANDHUBER BARBARA J , COLLIER JAMES , COOK ADAM , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , MCKNULTY OREN T , METCALF ANDREW T , MORENO DAVID A , RAMANN GINELLE A , TANG TONY P , REN LI , WALLS SHANE M
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: En el presente documento se proporcionan compuestos de Fórmula I: (I) o una de sus sales o solvatos farmacéuticamente aceptables, en la que A, B, X1, X2, X3, X4, Anillo D, E, Ra, Rb, n y m tienen los significados dados en la memoria descriptiva, que son inhibidores de la quinasa RET y son útiles en el tratamiento y prevención de enfermedades que pueden tratarse con un inhibidor de la quinasa RET, incluyendo enfermedades y trastornos asociados a RET. (Traducción automática con Google Translate, sin valor legal)
-
公开(公告)号:ES2922314T3
公开(公告)日:2022-09-13
申请号:ES19773595
申请日:2019-09-06
Applicant: ARRAY BIOPHARMA INC
Inventor: BLAKE JAMES F , DAI DONGHUA , HAAS JULIA , JIANG YUTONG , KAHN DEAN , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , METCALF ANDREW T , MORENO DAVID A , PRIGARO BRETT , RAMANN GINELLE A , REN LI , WALLS SHANE M , ZHANG HAILONG
IPC: C07D487/14 , A61K31/551 , A61P35/00 , C07D487/22 , C07D498/14 , C07D498/22
Abstract: Proporcionados en este documento hay compuestos de la fórmula (i): (i) y tautómeros, estereoisómeros y sales farmacéuticamente aceptables y solvatos de la misma, en donde rx, ry, w, x, y, z, anillo A y (aa) se dan los significados en La especificación, que son inhibidores de la quinasa RET y son útiles en el tratamiento y prevención de enfermedades que pueden tratarse con un inhibidor de la quinasa RET, incluidas las enfermedades y trastornos asociados con RET. (Traducción automática con Google Translate, sin valor legal)
-
公开(公告)号:SG11201903187WA
公开(公告)日:2019-05-30
申请号:SG11201903187W
申请日:2017-10-10
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN W , ARONOW SEAN , BLAKE JAMES F , BRANDHUBER BARBARA J , COLLIER JAMES , COOK ADAM , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , MCFADDIN ELIZABETH A , MCKENNEY MEGAN L , MCNULTY OREN T , METCALF ANDREW T , MORENO DAVID A , RAMANN GINELLE A , TANG TONY P , REN LI , WALLS SHANE M
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property MD HIM 0 11101 HOE HI 1 0 101110 Ell 010 HE 100 MO MIS Organization International Bureau (10) International Publication Number (43) International Publication Date ......0\" WO 2018/071454 Al 19 April 2018 (19.04.2018) WIP0 1 PCT (51) International Patent Classification: nut Street, Boulder, Colorado 80301 (US). MORENO, CO7D 471/04 (2006.01) A61P 35/00 (2006.01) David A. [US/US]; c/o Array BioPharma Inc., 3200 Walnut A61K 31/437 (2006.01) Street, Boulder, Colorado 80301 (US). RAMANN, Ginelle (21) International Application Number: A. [US/US]; c/o Array BioPharma, Inc., 3200 Walnut St., PCT/US2017/055993 Boulder, Colorado 80301 (US). TANG, Tony P. [US/US]; c/o Array BioPharma Inc., 3200 Walnut Street, Boulder, (22) International Filing Date: Colorado 80301 (US). REN, Li [US/US]; c/o Array Bio- 10 October 2017 (10.10.2017) Pharma Inc., 3200 Walnut Street, Boulder, Colorado 80301 (US). WALLS, Shane M. [US/US]; c/o Array BioPharma, (25) Filing Language: English Inc., 3200 Walnut St., Boulder, Colorado 80301 (US). (26) Publication Language: English (74) Agent: FOLLETT, Angela D. et al.; Fish & Richardson (30) Priority Data: P.C., P.O. Box 1022, Minneapolis, Minnesota 55440-1022 62/406,275 10 October 2016 (10.10.2016) US (US). 62/447,849 18 January 2017 (18.01.2017) US (81) Designated States (unless otherwise indicated, for every 62/491,180 27 April 2017 (27.04.2017) US kind of national protection available): AE, AG, AL, AM, 62/531,690 12 July 2017 (12.07.2017) US AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 62/566,030 29 September 2017 (29.09.2017) US CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (72) Inventors; and DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (71) Applicants: ANDREWS, Steven W. [US/US]; c/o Array HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, BioPharma Inc., 3200 Walnut Street, Boulder, Colorado KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 80301 (US). ARONOW, Sean [US/US]; c/o Array Bio- MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, Pharma, Inc., 3200 Walnut St., Boulder, Colorado 80301 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (US). BLAKE, James F. [US/US]; c/o Array BioPhar- SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, ma Inc., 3200 Walnut Street, Boulder, Colorado 80301 TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (US). BRANDHUBER, Barbara J. [US/US]; c/o Array (84) Designated States (unless otherwise indicated, for every BioPharma Inc., 3200 Walnut Street, Boulder, Colorado kind of regional protection available): ARIPO (BW, GH, 80301 (US). COLLIER, James [US/US]; c/o Array Bio GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, Pharma, Inc., 3200 Walnut St., Boulder, Colorado 80301 UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (US). COOK, Adam [US/US]; c/o Array BioPharma Inc., 3200 Walnut Street, Boulder, Colorado 80301 (US). HAAS, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, Julia [[JS/US]; c/o Array BioPharma Inc., 3200 Wal- MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, nut Street, Boulder, Colorado 80301 (US). JIANG, Yu- TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, tong [US/US]; c/o Array BioPharma Inc., 3200 Walnut KM, ML, MR, NE, SN, TD, TG). Street, Boulder, Colorado 80301 (US). KOLAKOWSKI, Gabrielle R. [US/US]; c/o Array BioPharma Inc., 3200 Published: Walnut Street, Boulder, Colorado 80301 (US). MCFAD- — DIN, Elizabeth A. [US/US]; c/o Array BioPharma, Inc., with international search report (Art. 21(3)) — with sequence listing part of description (Rule 5.2(a)) 3200 Walnut St., Boulder, Colorado 80301 (US). MCKEN- NEY, Megan L. [US/US]; c/o Array BioPharma, Inc., 3200 Walnut St., Boulder, Colorado 80301 (US). MCNULTY, Oren T. [US/US]; c/o Array BioPharma, Inc., 3200 Wal- nut St., Boulder, Colorado 80301 (US). METCALF, An- drew T. [US/US]; c/o Array BioPharma Inc., 3200 Wal- (54) Title: SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS (57) : Provided herein are compounds of the Formula I: (I) or pharmaceu- lin N i (Ra)„ tically acceptable salt or solvate thereof, wherein A, B, X 1 , X, X, X 2 3 4 , Ring D, E, 11' Il 1 X3=X2 R a , R b , n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which IN 0 p --.... / D ~X 4 _X~ d ca is rd n o b e e e tr rs . ated with a RET kinase inhibitor, including RET-associated diseases and X4-x1 B - O Il (Rb),„ © N I C
-
-
-
-
-
-
-
-
-